Lack of TIP30 expression could lead to late TNM clinic stage and lymph node metastasis: The prognostic significance of low expression of TIP30 in the TNM clinical stage was evaluated in 10 studies with 1351 patients. This evidence concerns the gene HTATIP2 and metastatic malignant neoplasm in the lymph nodes.